title: Experimental autoimmune uveoretinitis (EAU) in rats: isolation of S-antigen, EAU susceptibility of rat strains, genetic control of EAU induction, and effects of cyclophosphamide and irradiation on EAU.
abstract: Highly purified S-antigen was isolated from bovine retinas by high performance liquid chromatography (HPLC), and was used to induce experimental autoimmune uveoretinitis (EAU) in various rat strains. Studies were then made of the genetic control of EAU, the effects of cyclophosphamide or irradiation on EAU, and the correlation between the EAU incidence and the serum levels of antibody to S-antigen. Lewis rats were the most susceptible to EAU followed by Wistar rats. F344 rats and BN rats were resistant to EAU. (Lewis X BN)F1 rats and (LBNF1 X Lewis) rats were susceptible to EAU, while (LBNF1 X BN) rats were resistant. These results indicate that susceptibility to EAU was inherited as an autosomal dominant trait. Treatment of rats with cyclophosphamide or irradiation (200 rad/rat) on the day before immunization markedly suppressed EAU development. On the other hand, the same dose of irradiation 7 days after the immunization did not affect the disease induction, yet the antibody levels to S-antigen were very high in the rats. In addition, BN rats resistant to EAU exhibited very high levels of antibody to S-antigen. Therefore, the antibody to S-antigen seems to play a minor role, if any, in the immunopathogenic mechanisms of EAU.
authors.affiliation: Department of Ophthalmology, Yamagata University School of Medicine, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Suzuki
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Fujii
authors.forename: S
authors.initials: S
authors.lastname: Fuyama
authors.forename: S
authors.initials: S
authors.lastname: Arai
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology*; D019393:Arrestin; D001324:Autoantigens / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004198:Disease Susceptibility; D005136:Eye Proteins / Q000276:immunology*; D005260:Female; D005799:Genes, Dominant; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D012173:Retinitis / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D014606:Uveitis, Anterior / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D014916:Whole-Body Irradiation
chemical_list: D000941:Antigens; D019393:Arrestin; D001324:Autoantigens; D005136:Eye Proteins; D003520:Cyclophosphamide